Verrica Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 3.92, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Verrica Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 93 days, from 72 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 179 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1131, from overall ranking in the first quarter 2026 at 2220.

What is Receivable Turnover Ratio?
What is Verrica Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VRCA Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	18.99 %	36.64 %	6731.17 %	8289.29 %	-9.94 %
Y / Y Revenue Change	-53.85 %	46.06 %	1380.23 %	-	145.35 %
Receivable Turnover Ratio (TTM)	3.92	5.09	5.24	5.61	3.92
VRCA's Total Ranking	# 1131	# 2220	# 2115	# 1702	# 1349
Accounts Receivable average collection period days	93	72	70	65	93
Seq. Receivable Change	41.62 %	46.84 %	-25.36 %	-23.34 %	62.62 %
Seq. Revenue Change	16.7 %	-1.36 %	-64.5 %	12.93 %	269.35 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 44
Healthcare Sector	# 180
Overall Market	# 1131

Receivable Turnover Ratio Statistics
High	Average	Low
0.9	0.32	0.05
(Mar 31 2026)		(Sep 30 2023)

VRCA Company Profile • Back to VRCA Efficiency Comparisons • Compare VRCA Receivables Turnover Ratio to its Competitors

Financial Statements
Verrica Pharmaceuticals Inc 's Accounts Receivable	$ 11 Millions	Visit VRCA's Balance sheet
Verrica Pharmaceuticals Inc 's Sales TTM	$ 30 Millions	Visit VRCA's Income Statement
Sources of VRCA's Revenues		Visit VRCA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VRCA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VRCA's Growth Rates	VRCA's Roa	VRCA's Inventory Turnover Ratio	VRCA's Dividend Comparisons
VRCA's Profitability Ratios	VRCA's Roi	VRCA's Asset Turnover Ratio	VRCA's Dividend Growth
VRCA's Valuation Ratios	VRCA's Roe	VRCA's Financial Strength Ratios	VRCA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Acadia Pharmaceuticals Inc	7.56	$ 1,138.643 Millions	$ 150.596 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Aurinia Pharmaceuticals Inc	7.55	$ 311.507 Millions	$ 41.274 Millions
Solventum Corporation	7.52	$ 8,310.000 Millions	$ 1,105.500 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Novocure Limited	7.46	$ 699.193 Millions	$ 93.686 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions
Beta Bionics Inc	7.43	$ 119.513 Millions	$ 16.092 Millions
Seres Therapeutics Inc	7.42	$ 1.883 Millions	$ 0.254 Millions
Renovorx Inc	7.40	$ 1.976 Millions	$ 0.267 Millions
Maravai Lifesciences Holdings Inc	7.39	$ 207.886 Millions	$ 28.147 Millions
Koru Medical Systems Inc	7.38	$ 45.108 Millions	$ 6.114 Millions
Cerus Corporation	7.35	$ 221.224 Millions	$ 30.111 Millions
Lucid Diagnostics Inc	7.33	$ 5.445 Millions	$ 0.742 Millions
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions
Si bone inc	7.23	$ 214.331 Millions	$ 29.648 Millions
Safe Pro Group Inc	7.23	$ 2.881 Millions	$ 0.399 Millions
Insmed Inc	7.18	$ 1,076.572 Millions	$ 149.999 Millions
Rhythm Pharmaceuticals Inc	7.18	$ 239.918 Millions	$ 33.429 Millions
Twist Bioscience Corporation	7.10	$ 431.798 Millions	$ 60.812 Millions
Boston Scientific Corporation	7.10	$ 20,997.000 Millions	$ 2,957.500 Millions
Travere Therapeutics Inc	7.10	$ 591.330 Millions	$ 83.339 Millions
Angiodynamics Inc	7.08	$ 317.726 Millions	$ 44.853 Millions
Pulmonx Corporation	7.07	$ 87.393 Millions	$ 12.356 Millions
Arcturus Therapeutics Holdings Inc	7.05	$ 29.368 Millions	$ 4.168 Millions
Tandem Diabetes Care Inc	6.98	$ 1,037.302 Millions	$ 148.542 Millions

Date modified: 2026-09-05T15:39:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.